Healthcare Sector Stocks
The Healthcare sector has a total of 1060 stocks, with a combined market cap of $9.22 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 49.30.
Market Cap
9.22T
Revenue
4.66T
Profits
187.02B
PE Ratio
49.30
Profit Margin
4.01%
Dividend Yield
0.38%
1060 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.05T | -2.25% | 2,274,607 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 627.42B | -0.66% | 4,998,289 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 440.83B | -0.54% | 4,195,033 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 360.59B | 0.67% | 3,508,844 | 450.53B |
| 5 | MRK | Merck & Co., Inc. | 335.14B | 0.21% | 6,869,005 | 66.57B |
| 6 | NVS | Novartis AG | 286.74B | -0.55% | 1,597,683 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 240.81B | -0.50% | 3,697,885 | 61.37B |
| 8 | AMGN | Amgen Inc. | 224.48B | -0.63% | 2,036,769 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 217.52B | -1.28% | 1,057,645 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 201.92B | -1.78% | 10,853,741 | 50.34B |
| 11 | ABT | Abbott Laboratories | 192.51B | -0.02% | 5,575,445 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 171.56B | 0.16% | 3,407,726 | 30.46B |
| 13 | PFE | Pfizer Inc. | 152.69B | -0.04% | 23,174,742 | 63.70B |
| 14 | DHR | Danaher Corporation | 142.32B | -0.71% | 2,244,465 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 139.37B | -1.68% | 1,985,951 | 11.03B |
| 16 | BMY | Bristol-Myers Squibb Company | 130.39B | -1.27% | 7,529,797 | 49.19B |
| 17 | SYK | Stryker Corporation | 130.11B | -0.55% | 2,800,783 | 25.84B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 128.19B | -2.07% | 1,130,474 | 12.59B |
| 19 | CVS | CVS Health Corporation | 124.26B | 2.28% | 9,439,258 | 412.65B |
| 20 | MDT | Medtronic plc | 116.83B | 0.76% | 8,245,571 | 36.36B |
| 21 | SNY | Sanofi | 104.76B | -0.14% | 2,719,095 | 55.89B |
| 22 | MCK | McKesson Corporation | 101.32B | 1.44% | 614,387 | 410.98B |
| 23 | GSK | GSK plc | 98.67B | -0.97% | 3,722,992 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 87.61B | -1.71% | 936,782 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.82B | 0.53% | 730,752 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 80.23B | -0.31% | 425,601 | 15.53B |
| 27 | BSX | Boston Scientific Corporation | 75.11B | 0.27% | 16,297,739 | 21.00B |
| 28 | CI | The Cigna Group | 74.66B | 1.64% | 895,874 | 282.38B |
| 29 | COR | Cencora, Inc. | 59.89B | 1.43% | 1,524,210 | 332.77B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 56.30B | 1.38% | 3,137,292 | 28.42B |
| 31 | CAH | Cardinal Health, Inc. | 54.69B | 1.70% | 1,687,832 | 254.25B |
| 32 | ARGX | argenx SE | 52.87B | -0.66% | 278,668 | 5.32B |
| 33 | EW | Edwards Lifesciences Corporation | 52.80B | -1.04% | 2,852,610 | 6.51B |
| 34 | BDX | Becton, Dickinson and Company | 49.96B | 0.79% | 1,009,000 | 22.48B |
| 35 | MDLN | Medline Inc. | 46.99B | 0.45% | 2,755,723 | 29.94B |
| 36 | HUM | Humana Inc. | 46.72B | 1.06% | 761,091 | 145.68B |
| 37 | NTRA | Natera, Inc. | 44.67B | -0.27% | 1,273,563 | 2.71B |
| 38 | RVMD | Revolution Medicines, Inc. | 43.66B | 0.85% | 783,848 | - |
| 39 | IDXX | IDEXX Laboratories, Inc. | 43.41B | -2.82% | 453,501 | 4.55B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 42.85B | 0.68% | 2,332,454 | 17.32B |
| 41 | HLN | Haleon plc | 42.44B | -0.40% | 3,292,218 | 14.80B |
| 42 | A | Agilent Technologies, Inc. | 41.95B | -0.51% | 983,112 | 7.23B |
| 43 | WAT | Waters Corporation | 40.49B | -0.32% | 387,603 | 4.64B |
| 44 | VEEV | Veeva Systems Inc. | 39.60B | -3.52% | 1,426,024 | 3.32B |
| 45 | ONC | BeOne Medicines AG | 39.51B | -2.40% | 382,856 | 6.13B |
| 46 | IQV | IQVIA Holdings Inc. | 38.95B | -2.01% | 905,609 | 16.98B |
| 47 | ALC | Alcon Inc. | 36.14B | 0.99% | 1,158,611 | 10.86B |
| 48 | DXCM | DexCom, Inc. | 33.87B | -1.89% | 3,858,905 | 4.97B |
| 49 | RPRX | Royalty Pharma plc | 33.70B | 0.47% | 1,596,476 | 2.54B |
| 50 | CNC | Centene Corporation | 33.33B | 2.17% | 2,267,801 | 180.30B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 33.28B | -0.14% | 1,623,355 | 21.27B |
| 52 | RMD | ResMed Inc. | 32.38B | -1.01% | 1,193,124 | 5.65B |
| 53 | BIIB | Biogen Inc. | 31.00B | -0.39% | 554,664 | 10.03B |
| 54 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.60B | 0.67% | 1,525,906 | 4.80B |
| 55 | ZTS | Zoetis Inc. | 30.49B | -2.70% | 4,455,246 | 9.53B |
| 56 | ILMN | Illumina, Inc. | 28.82B | -0.91% | 993,013 | 4.49B |
| 57 | MTD | Mettler-Toledo International Inc. | 28.43B | -0.82% | 162,020 | 4.13B |
| 58 | INSM | Insmed Incorporated | 27.02B | -2.05% | 1,957,223 | 1.14B |
| 59 | PHG | Koninklijke Philips N.V. | 26.78B | -0.33% | 470,949 | 20.18B |
| 60 | ROIV | Roivant Sciences Ltd. | 26.15B | -0.22% | 4,527,331 | 7.53M |
| 61 | DGX | Quest Diagnostics Incorporated | 25.87B | -0.69% | 541,800 | 11.56B |
| 62 | LH | Labcorp Holdings Inc. | 25.80B | -1.38% | 436,290 | 14.35B |
| 63 | MRNA | Moderna, Inc. | 25.28B | -0.52% | 4,700,892 | 2.23B |
| 64 | WST | West Pharmaceutical Services, Inc. | 24.59B | 0.94% | 396,522 | 3.33B |
| 65 | INCY | Incyte Corporation | 24.36B | -0.30% | 785,740 | 5.82B |
| 66 | BNTX | BioNTech SE | 23.38B | 1.05% | 649,509 | 3.03B |
| 67 | STE | STERIS plc | 22.74B | -1.18% | 646,696 | 6.04B |
| 68 | THC | Tenet Healthcare Corporation | 21.57B | 0.32% | 529,987 | 21.81B |
| 69 | UTHR | United Therapeutics Corporation | 21.43B | -0.31% | 472,923 | 3.15B |
| 70 | GH | Guardant Health, Inc. | 21.10B | -1.46% | 2,564,771 | 1.18B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 19.20B | 1.08% | 2,152,736 | 8.51B |
| 72 | GMAB | Genmab A/S | 18.75B | 1.91% | 3,427,175 | 4.13B |
| 73 | VTRS | Viatris Inc. | 18.64B | 1.18% | 8,202,564 | 14.74B |
| 74 | ASND | Ascendis Pharma A/S | 16.32B | 0.92% | 650,345 | 1.20B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.15B | -0.59% | 220,617 | 2.78B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.90B | -0.36% | 542,036 | 4.60B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 15.61B | -1.66% | 3,094,030 | 713.07M |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.52B | 1.26% | 1,305,080 | 3.37B |
| 79 | SOLV | Solventum Corporation | 15.08B | 2.46% | 1,450,392 | 8.31B |
| 80 | COO | The Cooper Companies, Inc. | 14.86B | -0.56% | 887,052 | 4.23B |
| 81 | BAX | Baxter International Inc. | 13.82B | -1.18% | 4,957,165 | 11.47B |
| 82 | CRL | Charles River Laboratories International, Inc. | 13.37B | -0.43% | 750,354 | 4.00B |
| 83 | BMRN | BioMarin Pharmaceutical Inc. | 13.04B | -1.74% | 1,413,468 | 3.41B |
| 84 | RVTY | Revvity, Inc. | 13.04B | -0.56% | 774,553 | 2.91B |
| 85 | PEN | Penumbra, Inc. | 12.88B | 0.08% | 251,609 | 1.50B |
| 86 | ALGN | Align Technology, Inc. | 12.88B | 2.90% | 959,951 | 4.14B |
| 87 | BTSG | BrightSpring Health Services, Inc. | 12.86B | 2.46% | 1,605,839 | 14.37B |
| 88 | EXEL | Exelixis, Inc. | 12.70B | 1.24% | 2,342,499 | 2.44B |
| 89 | FMS | Fresenius Medical Care AG | 12.59B | 0.59% | 594,890 | 22.19B |
| 90 | ICLR | ICON Public Limited Company | 12.59B | -2.59% | 323,992 | 8.29B |
| 91 | SNN | Smith & Nephew plc | 12.49B | -1.00% | 1,069,002 | 6.30B |
| 92 | CORT | Corcept Therapeutics Incorporated | 12.37B | 3.58% | 728,887 | 830.81M |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.24B | 1.23% | 817,969 | 669.50M |
| 94 | EHC | Encompass Health Corporation | 12.19B | 0.03% | 633,980 | 6.21B |
| 95 | ELAN | Elanco Animal Health Incorporated | 11.83B | 5.15% | 6,496,969 | 5.02B |
| 96 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.73B | 0.04% | 234,655 | 1.28B |
| 97 | GMED | Globus Medical, Inc. | 11.53B | -0.05% | 864,749 | 3.14B |
| 98 | DVA | DaVita Inc. | 11.48B | 0.50% | 506,465 | 14.01B |
| 99 | TECH | Bio-Techne Corporation | 11.28B | 0.32% | 2,013,951 | 1.22B |
| 100 | HALO | Halozyme Therapeutics, Inc. | 11.20B | -2.00% | 1,659,273 | 1.66B |
| 101 | AXSM | Axsome Therapeutics, Inc. | 11.19B | - | 476,320 | 776.57M |
| 102 | MOH | Molina Healthcare, Inc. | 11.07B | 3.27% | 594,588 | 42.47B |
| 103 | GKOS | Glaukos Corporation | 10.88B | -2.60% | 742,290 | 612.84M |
| 104 | SMMT | Summit Therapeutics Inc. | 10.65B | -4.64% | 9,748,872 | - |
| 105 | ENSG | The Ensign Group, Inc. | 10.50B | -0.13% | 204,514 | 5.49B |
| 106 | RDY | Dr. Reddy's Laboratories Limited | 10.47B | -1.21% | 2,263,161 | 3.50B |
| 107 | CYTK | Cytokinetics, Incorporated | 10.31B | 0.93% | 1,756,858 | 67.67M |
| 108 | ABVX | ABIVAX Société Anonyme | 10.25B | -2.05% | 899,745 | 5.67M |
| 109 | PRAX | Praxis Precision Medicines, Inc. | 10.24B | -0.45% | 262,229 | 7.46M |
| 110 | APGE | Apogee Therapeutics, Inc. | 10.15B | 0.07% | 1,479,754 | - |
| 111 | OSCR | Oscar Health, Inc. | 10.10B | 6.43% | 6,595,047 | 15.32B |
| 112 | PTGX | Protagonist Therapeutics, Inc. | 10.04B | 2.43% | 426,255 | 281.99M |
| 113 | UHS | Universal Health Services, Inc. | 10.02B | -0.70% | 460,380 | 18.11B |
| 114 | HSIC | Henry Schein, Inc. | 10.00B | -0.39% | 1,162,477 | 13.60B |
| 115 | PODD | Insulet Corporation | 9.94B | -2.12% | 789,595 | 3.05B |
| 116 | KRYS | Krystal Biotech, Inc. | 9.83B | 1.20% | 167,863 | 440.48M |
| 117 | KYMR | Kymera Therapeutics, Inc. | 9.76B | 2.60% | 468,580 | 105.00M |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 9.53B | -1.36% | 173,817 | 2.59B |
| 119 | IONS | Ionis Pharmaceuticals, Inc. | 9.51B | 2.45% | 1,353,685 | 874.09M |
| 120 | RGEN | Repligen Corporation | 9.42B | -0.39% | 598,129 | 785.10M |
| 121 | TEM | Tempus AI, Inc. | 9.40B | -4.03% | 3,018,552 | 1.43B |
| 122 | AVTR | Avantor, Inc. | 9.24B | -1.37% | 3,964,757 | 6.56B |
| 123 | SYRE | Spyre Therapeutics, Inc. | 9.14B | 1.75% | 559,226 | - |
| 124 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.98B | 0.31% | 2,279,040 | 42.16M |
| 125 | QGEN | Qiagen N.V. | 8.88B | -0.65% | 3,673,766 | 2.10B |
| 126 | BRKR | Bruker Corporation | 8.79B | -0.40% | 1,230,713 | 3.50B |
| 127 | HQY | HealthEquity, Inc. | 8.76B | -0.81% | 606,015 | 1.34B |
| 128 | PCVX | Vaxcyte, Inc. | 8.64B | -1.34% | 656,558 | - |
| 129 | IMVT | Immunovant, Inc. | 8.64B | - | 722,452 | - |
| 130 | ATR | AptarGroup, Inc. | 8.40B | -0.35% | 381,603 | 3.93B |
| 131 | ALKS | Alkermes plc | 8.23B | -0.79% | 1,267,752 | 1.67B |
| 132 | IBRX | ImmunityBio, Inc. | 8.02B | -1.05% | 4,912,668 | 165.79M |
| 133 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.95B | -0.47% | 334,852 | 239.92M |
| 134 | TWST | Twist Bioscience Corporation | 7.44B | -5.36% | 1,140,424 | 431.80M |
| 135 | ORKA | Oruka Therapeutics, Inc. | 7.35B | 2.70% | 1,047,249 | - |
| 136 | TXG | 10x Genomics, Inc. | 7.31B | -3.54% | 2,014,090 | 616.91M |
| 137 | HNGE | Hinge Health, Inc. | 7.14B | 1.22% | 1,055,258 | 720.06M |
| 138 | PACS | PACS Group, Inc. | 7.04B | -1.22% | 698,421 | 5.55B |
| 139 | CHE | Chemed Corporation | 6.94B | -0.80% | 169,217 | 2.60B |
| 140 | TGTX | TG Therapeutics, Inc. | 6.91B | 1.67% | 1,073,261 | 799.54M |
| 141 | GRFS | Grifols, S.A. | 6.86B | -1.89% | 264,860 | 8.48B |
| 142 | LQDA | Liquidia Corporation | 6.66B | 3.25% | 2,516,003 | 450.91M |
| 143 | CGON | CG Oncology, Inc. | 6.65B | 0.43% | 596,273 | 6.23M |
| 144 | LNTH | Lantheus Holdings, Inc. | 6.59B | 0.01% | 1,263,591 | 1.56B |
| 145 | COGT | Cogent Biosciences, Inc. | 6.58B | 1.66% | 1,228,827 | - |
| 146 | HIMS | Hims & Hers Health, Inc. | 6.57B | -2.16% | 9,025,200 | 2.58B |
| 147 | MIRM | Mirum Pharmaceuticals, Inc. | 6.53B | 1.89% | 503,768 | 618.07M |
| 148 | DNTH | Dianthus Therapeutics, Inc. | 6.49B | 5.80% | 903,323 | 1.90M |
| 149 | ERAS | Erasca, Inc. | 6.43B | 2.91% | 2,465,949 | - |
| 150 | BLTE | Belite Bio, Inc | 6.40B | -2.09% | 228,799 | - |
| 151 | SRRK | Scholar Rock Holding Corporation | 6.40B | -1.02% | 496,596 | - |
| 152 | CAI | Caris Life Sciences, Inc. | 6.16B | -1.71% | 3,868,841 | 989.61M |
| 153 | BLCO | Bausch + Lomb Corporation | 6.09B | 0.41% | 237,064 | 5.32B |
| 154 | XENE | Xenon Pharmaceuticals Inc. | 6.04B | -2.93% | 921,774 | 7.50M |
| 155 | RDNT | RadNet, Inc. | 6.01B | -1.24% | 632,875 | 2.27B |
| 156 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.99B | -1.39% | 403,394 | 840.85M |
| 157 | PTCT | PTC Therapeutics, Inc. | 5.98B | -0.38% | 564,330 | 1.01B |
| 158 | LGND | Ligand Pharmaceuticals Incorporated | 5.87B | 2.00% | 197,207 | 290.54M |
| 159 | TVTX | Travere Therapeutics, Inc. | 5.86B | 1.16% | 1,190,556 | 591.33M |
| 160 | TFX | Teleflex Incorporated | 5.81B | 0.10% | 586,065 | 2.25B |
| 161 | AMRX | Amneal Pharmaceuticals, Inc. | 5.80B | 5.10% | 2,006,338 | 3.12B |
| 162 | STVN | Stevanato Group S.p.A. | 5.75B | -2.14% | 445,356 | 1.40B |
| 163 | DFTX | Definium Therapeutics, Inc. | 5.73B | -2.89% | 1,709,482 | - |
| 164 | MMED | MiniMed Group, Inc. | 5.66B | 0.65% | 1,069,127 | 3.10B |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.42B | 0.29% | 729,848 | 1.58B |
| 166 | SHC | Sotera Health Company | 5.39B | -0.68% | 1,558,423 | 1.22B |
| 167 | CRSP | CRISPR Therapeutics AG | 5.18B | -0.81% | 807,994 | 13.39M |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 4.87B | -0.49% | 1,062,474 | 1.14B |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.80B | -1.00% | 1,684,452 | - |
| 170 | EWTX | Edgewise Therapeutics, Inc. | 4.80B | 2.29% | 779,888 | - |
| 171 | WAY | Waystar Holding Corp. | 4.75B | -1.20% | 1,299,927 | 1.21B |
| 172 | LFST | LifeStance Health Group, Inc. | 4.75B | 1.64% | 5,186,647 | 1.58B |
| 173 | PBLS | Parabilis Medicines, Inc. | 4.72B | 3.92% | 290,893 | - |
| 174 | MANE | Veradermics, Incorporated | 4.71B | 1.54% | 523,467 | - |
| 175 | INDV | Indivior Pharmaceuticals, Inc. | 4.60B | 2.07% | 988,382 | 1.33B |
| 176 | ICUI | ICU Medical, Inc. | 4.58B | -0.07% | 191,759 | 2.16B |
| 177 | LIVN | LivaNova PLC | 4.53B | 0.02% | 559,432 | 1.47B |
| 178 | CON | Concentra Group Holdings Parent, Inc. | 4.52B | 0.88% | 811,531 | 2.29B |
| 179 | NVST | Envista Holdings Corporation | 4.51B | -0.04% | 2,525,213 | 2.86B |
| 180 | CELC | Celcuity Inc. | 4.50B | 6.24% | 1,333,508 | - |
| 181 | DOCS | Doximity, Inc. | 4.42B | -6.73% | 4,117,207 | 655.57M |
| 182 | BLLN | BillionToOne, Inc. | 4.40B | -0.75% | 480,856 | 397.41M |
| 183 | RLAY | Relay Therapeutics, Inc. | 4.35B | -0.35% | 1,530,218 | 10.35M |
| 184 | TNGX | Tango Therapeutics, Inc. | 4.32B | -0.19% | 1,439,357 | 53.81M |
| 185 | ELVN | Enliven Therapeutics, Inc. | 4.31B | 1.31% | 350,220 | - |
| 186 | ITGR | Integer Holdings Corporation | 4.26B | 0.16% | 368,655 | 1.84B |
| 187 | IRTC | iRhythm Holdings, Inc. | 4.17B | 2.66% | 485,074 | 825.34M |
| 188 | HAE | Haemonetics Corporation | 4.13B | 0.46% | 533,283 | 1.35B |
| 189 | TLX | Telix Pharmaceuticals Limited | 4.03B | -4.14% | 120,674 | 803.79M |
| 190 | ADPT | Adaptive Biotechnologies Corporation | 3.95B | 1.14% | 1,743,591 | 308.08M |
| 191 | LEGN | Legend Biotech Corporation | 3.94B | 0.49% | 2,017,451 | 1.27B |
| 192 | DNLI | Denali Therapeutics Inc. | 3.90B | -1.69% | 889,993 | 3.60M |
| 193 | GPCR | Structure Therapeutics Inc. | 3.89B | -0.35% | 555,889 | - |
| 194 | VKTX | Viking Therapeutics, Inc. | 3.87B | 0.76% | 1,180,618 | - |
| 195 | RCUS | Arcus Biosciences, Inc. | 3.75B | 2.15% | 1,150,675 | 117.00M |
| 196 | ABCL | AbCellera Biologics Inc. | 3.69B | 3.74% | 12,375,083 | 66.17M |
| 197 | HTFL | HeartFlow, Inc. | 3.66B | 35.70% | 9,913,524 | 212.07M |
| 198 | OGN | Organon & Co. | 3.60B | 0.15% | 2,113,279 | 6.13B |
| 199 | OPCH | Option Care Health, Inc. | 3.59B | -0.52% | 967,032 | 5.69B |
| 200 | IDYA | IDEAYA Biosciences, Inc. | 3.50B | -1.04% | 434,977 | 234.13M |
| 201 | NHC | National HealthCare Corporation | 3.50B | 1.71% | 178,315 | 1.56B |
| 202 | QURE | uniQure N.V. | 3.37B | 3.31% | 957,617 | 18.67M |
| 203 | VCYT | Veracyte, Inc. | 3.32B | -3.17% | 1,669,301 | 561.90M |
| 204 | MBX | MBX Biosciences, Inc. | 3.30B | 2.22% | 503,134 | - |
| 205 | CLDX | Celldex Therapeutics, Inc. | 3.29B | -1.55% | 849,360 | 158.00K |
| 206 | ARQT | Arcutis Biotherapeutics, Inc. | 3.29B | 1.39% | 1,109,468 | 463.98M |
| 207 | ALMS | Alumis Inc. | 3.28B | 3.69% | 1,217,186 | 7.40M |
| 208 | NAMS | NewAmsterdam Pharma Company N.V. | 3.23B | 1.16% | 959,578 | 7.12M |
| 209 | WRBY | Warby Parker Inc. | 3.20B | 0.12% | 2,794,781 | 911.61M |
| 210 | PLSE | Pulse Biosciences, Inc. | 3.18B | -0.85% | 401,103 | 1.19M |
| 211 | IOVA | Iovance Biotherapeutics, Inc. | 3.16B | 7.06% | 17,507,568 | 324.97M |
| 212 | IMNM | Immunome, Inc. | 3.09B | 2.95% | 760,763 | 4.02M |
| 213 | TMDX | TransMedics Group, Inc. | 3.07B | -1.18% | 433,802 | 668.47M |
| 214 | TARS | Tarsus Pharmaceuticals, Inc. | 3.04B | 0.46% | 448,239 | 606.33M |
| 215 | GRAL | GRAIL, Inc. | 3.03B | -0.54% | 433,178 | 165.26M |
| 216 | IRON | Disc Medicine, Inc. | 3.03B | -1.46% | 262,504 | - |
| 217 | BKD | Brookdale Senior Living Inc. | 3.02B | 0.72% | 3,583,354 | 2.93B |
| 218 | ZLAB | Zai Lab Limited | 2.91B | -0.50% | 1,234,001 | 449.61M |
| 219 | ALHC | Alignment Healthcare, Inc. | 2.90B | 3.71% | 3,633,693 | 4.58B |
| 220 | ACHC | Acadia Healthcare Company, Inc. | 2.87B | 1.95% | 1,103,271 | 3.37B |
| 221 | PRVA | Privia Health Group, Inc. | 2.81B | 1.10% | 676,455 | 2.36B |
| 222 | NRIX | Nurix Therapeutics, Inc. | 2.81B | -0.51% | 738,504 | 36.77M |
| 223 | SUPN | Supernus Pharmaceuticals, Inc. | 2.81B | 2.38% | 331,731 | 830.44M |
| 224 | RGC | Regencell Bioscience Holdings Limited | 2.70B | 4.01% | 132,178 | - |
| 225 | ATAI | AtaiBeckley Inc. | 2.69B | 0.14% | 6,100,062 | 4.47M |
| 226 | AVAH | Aveanna Healthcare Holdings Inc. | 2.69B | 9.12% | 7,334,202 | 2.60B |
| 227 | BEAM | Beam Therapeutics Inc. | 2.67B | 0.91% | 1,229,787 | 156.04M |
| 228 | TRVI | Trevi Therapeutics, Inc. | 2.63B | 1.71% | 1,389,735 | - |
| 229 | AXGN | Axogen, Inc. | 2.62B | 1.42% | 632,309 | 251.17M |
| 230 | RARE | Ultragenyx Pharmaceutical Inc. | 2.60B | 0.42% | 1,222,222 | 717.00M |
| 231 | KOD | Kodiak Sciences Inc. | 2.59B | 3.43% | 746,902 | - |
| 232 | SLS | SELLAS Life Sciences Group, Inc. | 2.58B | 3.40% | 4,412,824 | - |
| 233 | COAG | Hemab Therapeutics Holdings, Inc. | 2.57B | 1.84% | 101,166 | - |
| 234 | NEOG | Neogen Corporation | 2.54B | -2.02% | 1,586,171 | 870.40M |
| 235 | VRDN | Viridian Therapeutics, Inc. | 2.50B | 0.41% | 1,093,186 | 71.13M |
| 236 | NKTR | Nektar Therapeutics | 2.49B | -3.82% | 827,910 | 54.59M |
| 237 | UFPT | UFP Technologies, Inc. | 2.49B | 0.59% | 104,652 | 631.64M |
| 238 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.49B | -0.71% | 3,820,778 | 940.61M |
| 239 | PHVS | Pharvaris N.V. | 2.47B | 3.23% | 862,849 | - |
| 240 | CLOV | Clover Health Investments, Corp. | 2.44B | 2.45% | 3,657,459 | 2.48B |
| 241 | BHC | Bausch Health Companies Inc. | 2.43B | 2.68% | 2,560,555 | 10.85B |
| 242 | GRDN | Guardian Pharmacy Services, Inc. | 2.43B | -0.08% | 290,706 | 1.46B |
| 243 | PBH | Prestige Consumer Healthcare Inc. | 2.43B | 0.12% | 487,113 | 1.10B |
| 244 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.41B | -3.78% | 1,588,777 | -665.00K |
| 245 | ESTA | Establishment Labs Holdings Inc. | 2.37B | 5.13% | 496,984 | 245.82M |
| 246 | URGN | UroGen Pharma Ltd. | 2.36B | 0.21% | 458,056 | 188.73M |
| 247 | BFLY | Butterfly Network, Inc. | 2.35B | -0.23% | 5,255,950 | 112.14M |
| 248 | CDNA | CareDx, Inc. | 2.34B | -4.35% | 708,978 | 458.09M |
| 249 | WGS | GeneDx Holdings Corp. | 2.33B | -1.35% | 391,845 | 454.43M |
| 250 | KLRA | Kailera Therapeutics, Inc. | 2.33B | -0.17% | 335,982 | - |
| 251 | XRAY | DENTSPLY SIRONA Inc. | 2.31B | 0.09% | 2,713,536 | 3.64B |
| 252 | ALMR | Alamar Biosciences, Inc. | 2.30B | 0.73% | 161,135 | 100.42M |
| 253 | VERA | Vera Therapeutics, Inc. | 2.28B | 9.48% | 5,873,977 | - |
| 254 | RAPP | Rapport Therapeutics, Inc. | 2.28B | 0.13% | 159,830 | 20.00M |
| 255 | MLYS | Mineralys Therapeutics, Inc. | 2.27B | -1.72% | 697,736 | - |
| 256 | VCEL | Vericel Corporation | 2.26B | -0.76% | 276,053 | 306.30M |
| 257 | ATRC | AtriCure, Inc. | 2.25B | 1.86% | 340,858 | 569.62M |
| 258 | PVLA | Palvella Therapeutics, Inc. | 2.25B | -0.27% | 109,814 | - |
| 259 | HRMY | Harmony Biosciences Holdings, Inc. | 2.22B | -0.99% | 388,564 | 959.90M |
| 260 | BHVN | Biohaven Ltd. | 2.21B | -1.41% | 1,244,134 | - |
| 261 | OCUL | Ocular Therapeutix, Inc. | 2.20B | -0.59% | 1,634,134 | 52.06M |
| 262 | PGEN | Precigen, Inc. | 2.18B | -6.01% | 7,960,237 | 85.72M |
| 263 | NUVB | Nuvation Bio Inc. | 2.18B | 1.97% | 13,326,985 | 169.90M |
| 264 | HCM | HUTCHMED (China) Limited | 2.18B | 0.33% | 13,089 | 549.12M |
| 265 | ADUS | Addus HomeCare Corporation | 2.12B | -1.30% | 119,481 | 1.48B |
| 266 | ADMA | ADMA Biologics, Inc. | 2.12B | 0.64% | 1,308,515 | 512.28M |
| 267 | MD | Pediatrix Medical Group, Inc. | 2.11B | 0.91% | 607,139 | 1.95B |
| 268 | ASTH | Astrana Health, Inc. | 2.09B | 7.99% | 539,471 | 3.84B |
| 269 | SEPN | Septerna, Inc. | 2.08B | -1.42% | 630,342 | 98.88M |
| 270 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 1.91% | 827,250 | 311.51M |
| 271 | NEO | NeoGenomics, Inc. | 2.05B | -2.75% | 905,966 | 766.30M |
| 272 | MESO | Mesoblast Limited | 2.04B | -5.43% | 164,754 | 65.38M |
| 273 | GHRS | GH Research PLC | 2.02B | 4.61% | 233,831 | - |
| 274 | STOK | Stoke Therapeutics, Inc. | 2.02B | -0.13% | 495,115 | 27.59M |
| 275 | PGNY | Progyny, Inc. | 2.02B | 1.51% | 850,475 | 1.31B |
| 276 | GENB | Generate Biomedicines, Inc. | 2.01B | 4.06% | 310,803 | 26.48M |
| 277 | AGIO | Agios Pharmaceuticals, Inc. | 2.00B | 0.27% | 1,124,468 | 98.34M |
| 278 | NVCR | NovoCure Limited | 1.97B | -2.47% | 681,317 | 699.19M |
| 279 | SGRY | Surgery Partners, Inc. | 1.95B | -1.05% | 1,619,317 | 3.37B |
| 280 | TSHA | Taysha Gene Therapies, Inc. | 1.94B | -0.67% | 2,131,325 | 5.49M |
| 281 | FBRX | Forte Biosciences, Inc. | 1.94B | -0.04% | 489,432 | - |
| 282 | ZBIO | Zenas BioPharma, Inc. | 1.92B | 1.06% | 630,043 | 1.00M |
| 283 | DMRA | Damora Therapeutics, Inc. | 1.92B | 1.01% | 260,656 | - |
| 284 | SRPT | Sarepta Therapeutics, Inc. | 1.91B | -1.74% | 1,561,118 | 1.97B |
| 285 | NBTX | Nanobiotix S.A. | 1.90B | 0.37% | 238,331 | 38.27M |
| 286 | KARD | Kardigan, Inc. | 1.89B | -7.38% | 144,677 | - |
| 287 | LMAT | LeMaitre Vascular, Inc. | 1.88B | 0.55% | 553,268 | 262.43M |
| 288 | CMPS | COMPASS Pathways plc | 1.86B | 1.20% | 1,357,291 | - |
| 289 | TRLV | Trulieve Cannabis Corp. | 1.86B | 0.52% | 766,243 | 1.14B |
| 290 | SNDA | Sonida Senior Living, Inc. | 1.85B | -0.20% | 294,038 | 481.07M |
| 291 | LKFT | Lakefront Biotherapeutics NV | 1.82B | -1.82% | 249,331 | 1.13B |
| 292 | PRGO | Perrigo Company plc | 1.81B | 1.64% | 2,062,432 | 4.14B |
| 293 | ZYME | Zymeworks Inc. | 1.78B | -2.48% | 332,532 | 37.13M |
| 294 | SNDX | Syndax Pharmaceuticals, Inc. | 1.77B | 3.98% | 1,251,100 | 252.25M |
| 295 | IMCR | Immunocore Holdings plc | 1.76B | 0.03% | 195,190 | 430.78M |
| 296 | AVLN | Avalyn Pharma Inc. | 1.74B | 7.30% | 193,374 | - |
| 297 | XNCR | Xencor, Inc. | 1.74B | 1.52% | 443,052 | 104.97M |
| 298 | BRVE | Braveheart Bio, Inc. | 1.73B | 4.08% | 330,008 | - |
| 299 | ANAB | AnaptysBio, Inc. | 1.73B | 4.37% | 330,819 | 232.39M |
| 300 | BLFS | BioLife Solutions, Inc. | 1.72B | -0.45% | 478,677 | 106.69M |
| 301 | OMCL | Omnicell, Inc. | 1.70B | -0.90% | 393,437 | 1.25B |
| 302 | RXRX | Recursion Pharmaceuticals, Inc. | 1.69B | -4.53% | 10,545,071 | 54.86M |
| 303 | AAPG | Ascentage Pharma Group International | 1.69B | -1.32% | 185 | 82.08M |
| 304 | ETON | Eton Pharmaceuticals, Inc. | 1.68B | 44.26% | 2,318,188 | 105.60M |
| 305 | NTLA | Intellia Therapeutics, Inc. | 1.67B | 0.68% | 2,360,909 | 59.51M |
| 306 | FTRE | Fortrea Holdings Inc. | 1.66B | -2.30% | 2,561,091 | 2.68B |
| 307 | INSP | Inspire Medical Systems, Inc. | 1.65B | -1.89% | 396,913 | 898.74M |
| 308 | KMTS | Kestra Medical Technologies, Ltd. | 1.64B | 1.01% | 179,475 | 95.13M |
| 309 | ANIP | ANI Pharmaceuticals, Inc. | 1.64B | 2.37% | 236,757 | 978.38M |
| 310 | AGL | agilon health, inc. | 1.63B | 9.00% | 201,149 | 5.92B |
| 311 | BCAX | Bicara Therapeutics Inc. | 1.61B | 2.75% | 479,905 | - |
| 312 | TNDM | Tandem Diabetes Care, Inc. | 1.58B | -1.77% | 1,686,884 | 1.04B |
| 313 | ABSI | Absci Corporation | 1.58B | -2.96% | 2,231,297 | 1.56M |
| 314 | TRAX | First Tracks Biotherapeutics, Inc. | 1.57B | 0.02% | 446,150 | - |
| 315 | JBIO | Jade Biosciences, Inc. | 1.57B | 3.78% | 1,478,343 | - |
| 316 | XERS | Xeris Biopharma Holdings, Inc. | 1.57B | 3.24% | 1,366,214 | 335.41M |
| 317 | VIR | Vir Biotechnology, Inc. | 1.56B | 2.67% | 1,016,261 | 303.23M |
| 318 | LBRX | LB Pharmaceuticals Inc | 1.54B | 7.92% | 295,327 | - |
| 319 | ARDT | Ardent Health, Inc. | 1.54B | -1.00% | 250,364 | 6.41B |
| 320 | INVA | Innoviva, Inc. | 1.53B | 2.12% | 448,805 | 440.00M |
| 321 | ATEC | Alphatec Holdings, Inc. | 1.51B | 0.41% | 1,759,150 | 815.05M |
| 322 | CNMD | CONMED Corporation | 1.51B | 1.18% | 232,912 | 1.37B |
| 323 | MAZE | Maze Therapeutics, Inc. | 1.51B | -1.77% | 230,636 | 20.00M |
| 324 | TYRA | Tyra Biosciences, Inc. | 1.51B | 1.08% | 420,518 | - |
| 325 | ENOV | Enovis Corporation | 1.50B | 1.56% | 866,599 | 2.30B |
| 326 | HROW | Harrow, Inc. | 1.50B | 2.98% | 513,306 | 275.59M |
| 327 | PSNL | Personalis, Inc. | 1.50B | -2.64% | 1,042,604 | 69.67M |
| 328 | HCSG | Healthcare Services Group, Inc. | 1.48B | 2.37% | 837,888 | 1.86B |
| 329 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.48B | -1.38% | 2,378,030 | 208.78M |
| 330 | OMDA | Omada Health, Inc. | 1.47B | -1.35% | 948,421 | 309.76M |
| 331 | AZTA | Azenta, Inc. | 1.46B | -1.56% | 497,775 | 613.81M |
| 332 | AVBP | ArriVent BioPharma, Inc. | 1.46B | -1.63% | 438,963 | - |
| 333 | ALVO | Alvotech | 1.45B | -0.86% | 607,223 | 562.04M |
| 334 | INNV | InnovAge Holding Corp. | 1.44B | -0.38% | 213,456 | 949.17M |
| 335 | ORIC | ORIC Pharmaceuticals, Inc. | 1.44B | 1.09% | 828,503 | - |
| 336 | IART | Integra LifeSciences Holdings Corporation | 1.43B | 0.55% | 451,191 | 1.65B |
| 337 | AORT | Artivion, Inc. | 1.42B | 2.57% | 837,875 | 471.47M |
| 338 | REPL | Replimune Group, Inc. | 1.41B | -1.45% | 2,398,900 | - |
| 339 | MLTX | MoonLake Immunotherapeutics | 1.40B | -0.18% | 981,603 | - |
| 340 | PAHC | Phibro Animal Health Corporation | 1.39B | 0.88% | 110,779 | 1.50B |
| 341 | AKTS | Aktis Oncology, Inc. | 1.39B | 4.79% | 229,625 | 10.06M |
| 342 | PNTG | The Pennant Group, Inc. | 1.37B | 1.76% | 226,414 | 1.10B |
| 343 | SVRA | Savara Inc. | 1.37B | 2.09% | 1,649,954 | - |
| 344 | VOR | Vor Biopharma Inc. | 1.36B | -1.12% | 417,541 | - |
| 345 | AMN | AMN Healthcare Services, Inc. | 1.34B | 0.03% | 439,157 | 3.43B |
| 346 | NVAX | Novavax, Inc. | 1.33B | -1.11% | 2,279,529 | 413.80M |
| 347 | GLUE | Monte Rosa Therapeutics, Inc. | 1.32B | -2.15% | 509,489 | 28.73M |
| 348 | SDGR | Schrödinger, Inc. | 1.32B | -4.71% | 948,802 | 259.04M |
| 349 | DRTS | Alpha Tau Medical Ltd. | 1.32B | -1.72% | 314,739 | - |
| 350 | STAA | STAAR Surgical Company | 1.31B | 3.36% | 993,718 | 339.59M |
| 351 | CGEM | Cullinan Therapeutics, Inc. | 1.31B | 3.56% | 565,503 | - |
| 352 | FRNM | Freenome, Inc. | 1.30B | -0.43% | 775,639 | 34.24M |
| 353 | INBX | Inhibrx Biosciences, Inc. | 1.30B | -8.91% | 268,188 | 1.30M |
| 354 | MGTX | MeiraGTx Holdings plc | 1.30B | 6.71% | 809,173 | 397.50M |
| 355 | SPTX | Seaport Therapeutics, Inc. | 1.30B | 2.15% | 121,146 | - |
| 356 | IMTX | Immatics N.V. | 1.29B | -1.56% | 362,688 | 43.00M |
| 357 | NUTX | Nutex Health Inc. | 1.28B | 0.33% | 149,423 | 846.72M |
| 358 | GDRX | GoodRx Holdings, Inc. | 1.27B | 0.27% | 1,849,004 | 785.23M |
| 359 | EYPT | EyePoint, Inc. | 1.27B | 9.42% | 2,510,863 | 2.79M |
| 360 | APMD | Apnimed, Inc. | 1.26B | 10.28% | 650,927 | 120.15M |
| 361 | ANRO | Alto Neuroscience, Inc. | 1.26B | -0.50% | 874,487 | - |
| 362 | CRVS | Corvus Pharmaceuticals, Inc. | 1.25B | -1.65% | 777,869 | - |
| 363 | OMER | Omeros Corporation | 1.24B | -0.92% | 3,675,975 | 38.42M |
| 364 | PRCT | PROCEPT BioRobotics Corporation | 1.24B | -1.37% | 751,428 | 337.34M |
| 365 | MNKD | MannKind Corporation | 1.24B | 3.22% | 2,855,339 | 393.63M |
| 366 | TDOC | Teladoc Health, Inc. | 1.24B | -2.16% | 3,075,243 | 2.49B |
| 367 | LTGO | Latigo Biotherapeutics, Inc. | 1.23B | -2.84% | 303,585 | - |
| 368 | CERT | Certara, Inc. | 1.22B | -1.84% | 1,429,307 | 421.75M |
| 369 | USPH | U.S. Physical Therapy, Inc. | 1.21B | -1.84% | 364,060 | 804.27M |
| 370 | BVS | Bioventus Inc. | 1.20B | 2.66% | 506,038 | 581.85M |
| 371 | CRON | Cronos Group Inc. | 1.16B | -0.63% | 1,026,789 | 179.09M |
| 372 | LMRI | Lumexa Imaging Holdings, Inc. | 1.15B | -1.48% | 616,346 | 1.04B |
| 373 | IRMD | IRADIMED CORPORATION | 1.11B | -0.01% | 142,684 | 86.34M |
| 374 | AHG | Akso Health Group | 1.09B | -2.31% | 9,769 | 13.83M |
| 375 | WVE | Wave Life Sciences Ltd. | 1.07B | 4.04% | 2,884,410 | 65.37M |
| 376 | SANA | Sana Biotechnology, Inc. | 1.06B | -3.27% | 3,705,707 | - |
| 377 | IVA | Inventiva S.A. | 1.06B | - | 573,820 | 7.94M |
| 378 | AVTX | Avalo Therapeutics, Inc. | 1.05B | 0.72% | 388,066 | 59.00K |
| 379 | GMRS | GMR Solutions Inc. | 1.03B | -4.66% | 1,179,399 | 5.88B |
| 380 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | -0.85% | 1,762,684 | 41.47M |
| 381 | OPK | OPKO Health, Inc. | 1.03B | -1.43% | 3,284,020 | 587.90M |
| 382 | ARDX | Ardelyx, Inc. | 1.01B | 3.84% | 3,978,332 | 450.89M |
| 383 | ANNX | Annexon, Inc. | 1.00B | 0.57% | 2,990,237 | - |
| 384 | ODTX | Odyssey Therapeutics, Inc. | 993.35M | 0.05% | 136,326 | 99.00K |
| 385 | SLDB | Solid Biosciences Inc. | 986.47M | 1.32% | 759,399 | - |
| 386 | JANX | Janux Therapeutics, Inc. | 985.52M | 0.75% | 441,506 | 24.00M |
| 387 | QDEL | QuidelOrtho Corporation | 980.63M | -5.24% | 917,895 | 2.67B |
| 388 | KURA | Kura Oncology, Inc. | 966.11M | 7.63% | 1,885,760 | 77.23M |
| 389 | GERN | Geron Corporation | 944.44M | -4.23% | 11,157,886 | 204.56M |
| 390 | CLYM | Climb Bio, Inc. | 937.93M | 10.86% | 2,498,136 | - |
| 391 | OLMA | Olema Pharmaceuticals, Inc. | 930.10M | 1.14% | 1,163,087 | - |
| 392 | DSGN | Design Therapeutics, Inc. | 928.09M | 3.06% | 259,838 | - |
| 393 | ABUS | Arbutus Biopharma Corporation | 923.95M | 1.97% | 1,438,696 | 181.72M |
| 394 | COLL | Collegium Pharmaceutical, Inc. | 919.04M | 0.28% | 695,302 | 808.21M |
| 395 | PCRX | Pacira BioSciences, Inc. | 916.82M | -0.78% | 645,093 | 746.16M |
| 396 | AVR | Anteris Technologies Global Corp. | 916.11M | 5.26% | 683,455 | 2.24M |
| 397 | CSTL | Castle Biosciences, Inc. | 904.88M | -3.04% | 264,210 | 357.28M |
| 398 | CADL | Candel Therapeutics, Inc. | 896.80M | -0.68% | 2,069,256 | - |
| 399 | CBLL | CeriBell, Inc. | 895.36M | 0.34% | 296,038 | 101.96M |
| 400 | AMPH | Amphastar Pharmaceuticals, Inc. | 889.47M | 3.62% | 305,681 | 730.02M |
| 401 | TBPH | Theravance Biopharma, Inc. | 881.06M | 0.30% | 405,435 | 104.31M |
| 402 | SGP | SpyGlass Pharma, Inc. | 876.34M | 4.09% | 69,689 | - |
| 403 | INMD | InMode Ltd. | 870.83M | -0.33% | 350,547 | 374.63M |
| 404 | TALK | Talkspace, Inc. | 870.58M | - | 2,409,395 | 245.73M |
| 405 | ATTO | Attovia Therapeutics, Inc. | 854.56M | 3.55% | 98,155 | 1.35M |
| 406 | ACRS | Aclaris Therapeutics, Inc. | 850.81M | -1.37% | 666,222 | 8.22M |
| 407 | SIBN | SI-BONE, Inc. | 848.42M | -0.11% | 206,745 | 213.60M |
| 408 | HSTM | HealthStream, Inc. | 846.20M | -0.28% | 145,303 | 321.12M |
| 409 | GLAS | Glass House Brands Inc. | 843.91M | -5.62% | 381,323 | 177.68M |
| 410 | FTH | Faeth Therapeutics, Inc. | 835.68M | 13.27% | 365,040 | - |
| 411 | SLN | Silence Therapeutics plc | 826.07M | -1.79% | 823,935 | 615.00K |
| 412 | PHAR | Pharming Group N.V. | 814.40M | -5.10% | 20,712 | 366.48M |
| 413 | DBVT | DBV Technologies S.A. | 810.62M | -0.07% | 128,541 | 5.04M |
| 414 | OCS | Oculis Holding AG | 798.81M | 0.94% | 125,378 | 1.45M |
| 415 | AURA | Aura Biosciences, Inc. | 797.49M | 0.52% | 684,461 | - |
| 416 | RIGL | Rigel Pharmaceuticals, Inc. | 795.39M | 4.39% | 223,974 | 276.79M |
| 417 | BBNX | Beta Bionics, Inc. | 790.47M | -2.82% | 935,923 | 119.01M |
| 418 | IMMX | Immix Biopharma, Inc. | 784.79M | 0.46% | 1,295,413 | - |
| 419 | ACHV | Achieve Life Sciences, Inc. | 781.03M | 4.69% | 1,743,442 | - |
| 420 | VREX | Varex Imaging Corporation | 779.32M | -0.05% | 702,305 | 865.00M |
| 421 | SSII | SS Innovations International, Inc. | 778.51M | 1.57% | 21,168 | 52.40M |
| 422 | AHCO | AdaptHealth Corp. | 775.11M | 1.93% | 2,351,306 | 3.36B |
| 423 | OBX | Obsidian Therapeutics, Inc. | 769.91M | -6.08% | 32,771 | - |
| 424 | DRUG | Bright Minds Biosciences Inc. | 762.98M | -2.00% | 151,384 | - |
| 425 | PHAT | Phathom Pharmaceuticals, Inc. | 760.94M | 4.36% | 968,846 | 239.66M |
| 426 | PHR | Phreesia, Inc. | 759.05M | -2.69% | 436,668 | 495.59M |
| 427 | MNPR | Monopar Therapeutics Inc. | 758.74M | 2.38% | 165,719 | - |
| 428 | STTK | Shattuck Labs, Inc. | 744.70M | 1.37% | 640,740 | 1.00M |
| 429 | HELP | Cybin Inc. | 743.19M | 4.72% | 1,524,729 | - |
| 430 | CBIO | Crescent Biopharma, Inc. | 733.61M | 3.07% | 229,860 | 11.88M |
| 431 | CTMX | CytomX Therapeutics, Inc. | 732.14M | 0.30% | 1,433,000 | 18.30M |
| 432 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 725.77M | -1.84% | 227,475 | - |
| 433 | NGNE | Neurogene Inc. | 723.21M | 1.43% | 115,859 | 925.00K |
| 434 | IRWD | Ironwood Pharmaceuticals, Inc. | 712.18M | 5.64% | 2,334,027 | 389.32M |
| 435 | RGNX | REGENXBIO Inc. | 710.63M | 0.98% | 792,486 | 174.48M |
| 436 | EVO | Evotec SE | 709.19M | -2.97% | 41,956 | 819.47M |
| 437 | GYRE | Gyre Therapeutics, Inc. | 708.31M | 2.14% | 52,735 | 109.82M |
| 438 | ALLO | Allogene Therapeutics, Inc. | 708.26M | 3.54% | 4,605,119 | 4.64M |
| 439 | TECX | Tectonic Therapeutic, Inc. | 682.47M | 2.74% | 84,238 | - |
| 440 | FDMT | 4D Molecular Therapeutics, Inc. | 673.43M | 4.64% | 773,744 | 92.01M |
| 441 | ZVRA | Zevra Therapeutics, Inc. | 672.22M | 1.25% | 777,759 | 136.07M |
| 442 | ASMB | Assembly Biosciences, Inc. | 670.88M | 10.02% | 559,104 | 74.85M |
| 443 | BWAY | BrainsWay Ltd. | 660.92M | -0.79% | 120,963 | 60.70M |
| 444 | VALN | Valneva SE | 658.72M | 26.19% | 2,882,842 | 163.30M |
| 445 | STLN | Starling Oncology, Inc. | 657.36M | 3.04% | 1,086,837 | 587.24M |
| 446 | SGMT | Sagimet Biosciences Inc. | 655.77M | 13.69% | 2,659,469 | - |
| 447 | ANGO | AngioDynamics, Inc. | 655.12M | 1.21% | 330,037 | 320.17M |
| 448 | AGMB | AgomAb Therapeutics NV | 651.06M | -5.23% | 41,982 | - |
| 449 | KIDS | OrthoPediatrics Corp. | 647.52M | -0.84% | 132,768 | 252.72M |
| 450 | CTEV | Claritev Corporation | 646.04M | -9.71% | 133,153 | 994.67M |
| 451 | SOPH | SOPHiA GENETICS SA | 638.46M | -1.57% | 193,278 | 86.17M |
| 452 | TLRY | Tilray Brands, Inc. | 633.32M | -0.64% | 3,269,410 | 915.45M |
| 453 | MDXG | MiMedx Group, Inc. | 622.40M | 1.67% | 974,754 | 355.17M |
| 454 | NVCT | Nuvectis Pharma, Inc. | 617.75M | -1.40% | 106,659 | - |
| 455 | CTKB | Cytek Biosciences, Inc. | 609.62M | -4.09% | 927,484 | 206.71M |
| 456 | CERS | Cerus Corporation | 600.54M | 4.93% | 2,488,992 | 221.55M |
| 457 | EIKN | Eikon Therapeutics, Inc. | 598.52M | 6.97% | 637,716 | - |
| 458 | VSTM | Verastem, Inc. | 595.91M | -1.35% | 1,279,892 | 87.53M |
| 459 | CRMD | CorMedix Inc. | 587.70M | -7.37% | 2,701,404 | 462.25M |
| 460 | ARVN | Arvinas, Inc. | 586.51M | -0.44% | 461,290 | 316.70M |
| 461 | DCTH | Delcath Systems, Inc. | 580.51M | -3.63% | 529,510 | 95.42M |
| 462 | AUTL | Autolus Therapeutics plc | 572.21M | -3.15% | 2,395,470 | 117.39M |
| 463 | ALT | Altimmune, Inc. | 571.88M | 2.08% | 3,073,959 | 31.00K |
| 464 | PRLD | Prelude Therapeutics Incorporated | 571.62M | 3.54% | 452,061 | 22.42M |
| 465 | SPRY | ARS Pharmaceuticals, Inc. | 561.88M | -7.38% | 5,045,919 | 116.93M |
| 466 | ARTV | Artiva Biotherapeutics, Inc. | 559.79M | 1.33% | 264,405 | 251.00K |
| 467 | OVID | Ovid Therapeutics Inc. | 552.69M | 1.07% | 1,240,940 | 1.58M |
| 468 | PRME | Prime Medicine, Inc. | 549.72M | -2.52% | 1,571,020 | 4.07M |
| 469 | TCMD | Tactile Systems Technology, Inc. | 548.19M | 2.07% | 364,496 | 350.31M |
| 470 | MPLT | MapLight Therapeutics, Inc. | 544.94M | 1.47% | 451,766 | - |
| 471 | EOLS | Evolus, Inc. | 538.64M | 1.68% | 648,703 | 316.49M |
| 472 | CTNM | Contineum Therapeutics, Inc. | 533.84M | -7.25% | 747,305 | - |
| 473 | ZURA | Zura Bio Limited | 533.77M | -1.07% | 793,483 | - |
| 474 | AQST | Aquestive Therapeutics, Inc. | 533.42M | - | 4,350,128 | 54.09M |
| 475 | EVMN | Evommune, Inc. | 531.68M | 4.12% | 362,380 | 10.00M |
| 476 | ANL | Adlai Nortye Ltd. | 530.00M | 3.03% | 56,285 | 19.54M |
| 477 | EVH | Evolent Health, Inc. | 529.12M | 0.43% | 2,290,664 | 2.10B |
| 478 | SRTA | Strata Critical Medical, Inc. | 521.95M | -1.17% | 612,300 | 255.98M |
| 479 | CCCC | C4 Therapeutics, Inc. | 521.63M | 3.92% | 3,399,045 | 35.04M |
| 480 | RLMD | Relmada Therapeutics, Inc. | 512.02M | 1.05% | 925,427 | - |
| 481 | FLGT | Fulgent Genetics, Inc. | 510.68M | -0.48% | 140,467 | 323.93M |
| 482 | NPCE | NeuroPace, Inc. | 506.97M | 1.79% | 154,948 | 106.99M |
| 483 | KYTX | Kyverna Therapeutics, Inc. | 505.26M | 1.11% | 579,854 | - |
| 484 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 485 | ENTX | Entera Bio Ltd. | 500.38M | 0.70% | 278,075 | 42.00K |
| 486 | BLSM | BlossomHill Therapeutics, Inc. | 495.81M | -1.04% | 323,931 | - |
| 487 | OABI | OmniAb, Inc. | 491.42M | -1.46% | 554,393 | 38.46M |
| 488 | BIOA | BioAge Labs, Inc. | 486.51M | 1.63% | 444,291 | 10.36M |
| 489 | RZLT | Rezolute, Inc. | 480.55M | - | 657,066 | - |
| 490 | NRC | NRC Health | 468.71M | -0.56% | 142,811 | 140.00M |
| 491 | CLPT | ClearPoint Neuro, Inc. | 467.93M | -0.52% | 299,271 | 42.28M |
| 492 | CABA | Cabaletta Bio, Inc. | 466.25M | 1.48% | 2,352,224 | - |
| 493 | OCGN | Ocugen, Inc. | 457.80M | - | 2,978,231 | 4.58M |
| 494 | DNA | Ginkgo Bioworks Holdings, Inc. | 457.24M | -6.22% | 1,451,274 | 132.42M |
| 495 | PBYI | Puma Biotechnology, Inc. | 455.81M | 1.38% | 233,031 | 231.24M |
| 496 | LRMR | Larimar Therapeutics, Inc. | 455.11M | 2.11% | 1,183,064 | - |
| 497 | PRTA | Prothena Corporation plc | 454.85M | -2.42% | 312,599 | 54.53M |
| 498 | QTTB | Q32 Bio Inc. | 451.01M | -1.43% | 313,004 | 53.74M |
| 499 | SGHT | Sight Sciences, Inc. | 448.42M | -2.16% | 331,877 | 83.38M |
| 500 | IKT | Inhibikase Therapeutics, Inc. | 438.80M | - | 227,863 | 1.00 |